Publications
-
Serra C, Vila R, del Cacho N, Butjosa A, Manuel Abella Villena, Colomer A, Cunill R, Tena MC, Véliz DI, Bustos-Cardona T, Dolz M, Profep Group and Usall J.
Association of perceived social support with sociodemographic, clinical, and psychosocial variables in patients with first-episode psychosis.
JOURNAL OF PSYCHIATRIC RESEARCH . 162: 30-36. Number of citations: 1
-
Parody-Rua E, Bustamante A, Montaner J, Rubio-Valera M, Serrano D, Pérez-Sánchez S, Sanchez A, Guevara-Cuellar C and Serrano-Blanco A.
Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients.
EUROPEAN JOURNAL OF HEALTH ECONOMICS . 24(4): 621-632. Number of citations: 2
-
Novais T, Fortini C, Dima AL, Schott AM, Viprey M and Schneider MP.
Se former à l’entretien motivationnel pour mieux soutenir l’adhésion thérapeutique des patients
Revue Medicale Suisse . 19(823): 777-781.
-
Sanabria JP, Doval E, Bernadàs A, Angarita-Osorio N, Colomer A, Evans-Lacko S, Thornicroft G, Luciano JV and Rubio-Valera M.
Over 40 years (1981-2023) assessing stigma with the Community Attitudes to Mental Illness (CAMI) scale: a systematic review of its psychometric properties
Systematic Reviews . 12(1): 66-66. Number of citations: 7
-
Lavalle R, Condominas E, Haro JM, Giné I, Bailon R, Laporta E, Garcia E, Kontaxis S, Alacid GR, Lombardini F, Preti A, Peñarrubia-María MT, Coromina M, Arranz B, Vilella E, Rubio E, Radar-Mdd Spain, Matcham F, Lamers F, Hotopf M, Penninx BWJH, Annas P, Narayan V, Simblett SK, Siddi S and The Radar-Cns Consortium.
The Impact of COVID-19 Lockdown on Adults with Major Depressive Disorder from Catalonia: A Decentralized Longitudinal Study.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 20(6): .
-
Kardas, P, Agh, T, Dima AL, Goetzinger, C, Potocnjak, I, Wettermark, B and van Boven, JFM.
Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?
Pharmaceutics . 15(3): . Number of citations: 3
-
Cuñat O, Del Hoyo-Buxo B, Vila R, Serra C, Butjosa A, del Cacho N, Colomer A, Dolz M, Cuevas-Esteban J, Iglesias M, Usall J and Profep Group.
Negative symptoms in drug-naive patients with a first-episode psychosis (FEP)
Asian Journal of Psychiatry . 81: 103448-103448. Number of citations: 1
-
Bhattacharya D, Brown TJ, Clark AB, Dima AL, Easthall C, Taylor N and Li Z.
Validation of the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q) ; a Behavioural Science-Underpinned Tool for Identifying Non-Adherence and Diagnosing an Individual's Barriers to Adherence
PATIENT PREFERENCE AND ADHERENCE . 17: 2991-3000. Number of citations: 1
-
Arias de la Torre J, Gemma Vilagut Saiz, Ronaldson A, Bakolis I, Dregan A, Navarro-Mateu F, Pérez K, Szücs A, Bartoll-Roca X, Molina AJ, Elices M, Pérez-Solá V, Martín V, Serrano-Blanco A, Valderas JM and Alonso J.
Reconsidering the Use of Population Health Surveys for Monitoring of Mental Health
JMIR Public Health and Surveillance . 9: 48138-48138. Number of citations: 1
-
Viprey M, Mougeot F, Dima AL, Haesebaert J, Occelli P, Durieu I, Rouzé H, Reynaud Q and Touzet S.
A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit
PATIENT PREFERENCE AND ADHERENCE . 17: 995-1004.